Skip to main content

Pasternak Andy's Form 4 filing

Horizon Therapeutics Public Ltd Co (HZNP) · filed Dec 14, 2022

Accession no.
0001209191-22-061269
Filed
Dec 14, 2022
Trade date
Dec 13, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.40M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Pasternak AndyCIK 0001792746Officer (EVP, Chief Strategy Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 13, 2022Ordinary SharesMOption exerciseAcquired+23,251$29.52+$686,369.5264,216Direct
Dec 13, 2022Ordinary SharesSSaleDisposed−23,251$112.61−$2,618,295.1140,965Direct
Dec 13, 2022Ordinary SharesSSaleDisposed−6,918$112.60−$778,966.834,047Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 13, 2022Ordinary SharesMOption exerciseDisposed−23,251$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)